Peter Ordentlich - Chief Scientific Officer at Syndax Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
SNDX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Peter Ordentlich since 12/22/2023

Holdings reported by Peter Ordentlich for Syndax Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $18.27 Feb 15, 2023 Direct
Stock Options (Right to buy) 0 $25.84 Feb 15, 2023 Direct Common Stock

Transactions reported by Peter Ordentlich for Syndax Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.